CRIS Current Research Information System

BENEVENTO, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.663
AS - Asia 1.068
EU - Europa 959
AF - Africa 112
SA - Sud America 62
Totale 3.864
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.649
SG - Singapore 390
CN - Cina 293
IT - Italia 190
VN - Vietnam 180
GB - Regno Unito 160
DE - Germania 156
SE - Svezia 122
HK - Hong Kong 80
NL - Olanda 62
IN - India 59
RU - Federazione Russa 48
IE - Irlanda 47
TG - Togo 42
BR - Brasile 39
FR - Francia 37
FI - Finlandia 28
CI - Costa d'Avorio 27
KR - Corea 23
CH - Svizzera 22
BG - Bulgaria 16
ZA - Sudafrica 16
BE - Belgio 11
EE - Estonia 11
JO - Giordania 11
SC - Seychelles 10
AR - Argentina 9
UA - Ucraina 9
HR - Croazia 8
NG - Nigeria 8
CA - Canada 7
ID - Indonesia 7
MK - Macedonia 6
AT - Austria 5
CL - Cile 5
PL - Polonia 5
UZ - Uzbekistan 5
JP - Giappone 4
LT - Lituania 4
MX - Messico 4
PK - Pakistan 4
ES - Italia 3
BD - Bangladesh 2
DZ - Algeria 2
EC - Ecuador 2
IQ - Iraq 2
LV - Lettonia 2
PE - Perù 2
SN - Senegal 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BY - Bielorussia 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MR - Mauritania 1
MU - Mauritius 1
PA - Panama 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 3.864
Salva come PNG Salva come JPEG
Città #
Singapore 258
Ashburn 253
Fairfield 173
Chandler 168
Southend 142
Dong Ket 100
Woodbridge 88
Hong Kong 79
Seattle 76
Santa Clara 69
Bologna 68
Houston 60
Wilmington 56
Boardman 51
Beijing 49
Dublin 47
Hefei 43
Princeton 43
Lomé 42
Cambridge 41
Ann Arbor 39
Dallas 38
Abidjan 27
New York 27
Ho Chi Minh City 25
Munich 25
Hanoi 23
Seoul 23
Bern 21
Los Angeles 21
Sofia 16
Redmond 14
Westminster 14
Turin 13
Buffalo 12
Falkenstein 12
Helsinki 12
Milan 12
Nanjing 12
Washington 12
Amman 11
Brussels 11
Shenyang 11
Berlin 10
Redondo Beach 10
Frankfurt am Main 9
Turku 9
Abeokuta 8
Bremen 8
Florence 8
Nuremberg 8
Shanghai 8
Lappeenranta 7
Padova 7
Saint Petersburg 7
Chicago 6
Des Moines 6
Fort Worth 6
Guangzhou 6
Jinan 6
London 6
Orem 6
Rome 6
Skopje 6
The Dalles 6
Zhengzhou 6
Amsterdam 5
Brooklyn 5
Jakarta 5
San Diego 5
Bengaluru 4
Chongqing 4
Da Nang 4
Haiphong 4
Mountain View 4
Paris 4
Redwood City 4
Taiyuan 4
Tokyo 4
Warsaw 4
Wuhan 4
Borgo Tossignano 3
Changsha 3
Chennai 3
Fremont 3
Haikou 3
Medford 3
Montreal 3
Nanchang 3
Napoli 3
Norwalk 3
Shijiazhuang 3
São Paulo 3
Ancona 2
Belo Horizonte 2
Bexley 2
Bühl 2
Can Tho 2
Chengdu 2
Dakar 2
Totale 2.616
Salva come PNG Salva come JPEG
Nome #
Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: experience of the Bologna Liver Oncology Group. 218
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 204
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 190
Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis 181
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 180
Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib 168
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 167
Pattern of macrovascular invasion in hepatocellular carcinoma 159
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 154
Anticoagulation in Cirrhotic Portal Vein Thrombosis: No Harm, but Survival Benefit Still Unclear 142
An update of treatments of hepatocellular carcinoma in patients refractory to sorafenib 140
Systemic treatments for hepatocellular carcinoma: challenges and future perspectives 136
Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients 125
Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure 124
Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: Correlation with MGMT promoter methylation status 123
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 121
Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma (Targeted Oncology, (2020), 15, 6, (773-785), 10.1007/s11523-020-00757-3) 120
Immunotherapy for hepatocellular carcinoma: A review of potential new drugs based on ongoing clinical studies as of 2019 117
null 117
Experience with regorafenib in the treatment of hepatocellular carcinoma 106
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma 104
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 104
SAT-453-Effects of sorafenib on pancreatic volume and their clinical implications in patients with hepatocellular carcinoma 100
Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery 98
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 97
Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative Analysis 82
null 77
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 75
An update on atezolizumab for hepatocellular carcinoma 68
Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma 56
null 56
Regorafenib Combined with Other Systemic Therapies: Exploring Promising Therapeutic Combinations in HCC 56
Totale 3.965
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.974
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.974
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021266 0 0 0 0 0 40 15 25 44 19 20 103
2021/2022507 52 7 15 21 46 32 9 33 19 31 178 64
2022/2023625 46 90 30 82 47 49 36 36 117 14 35 43
2023/2024291 16 50 29 18 41 64 10 19 21 11 5 7
2024/2025765 41 76 71 63 91 35 75 30 12 86 62 123
2025/2026870 182 151 155 118 189 75 0 0 0 0 0 0
Totale 3.965